Physician profile
Mary Mier
NPI 1134487804
$1,059.64
in general payments reported to CMS, 2019-2025
17 companies · $79.96 in 2025
The $79.96 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.31 · 2020: $170 · 2021: $575 · 2022: $21.79 · 2023: $143 · 2025: $79.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $223.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $304.40 | 2021 | |
| Dexcom, INC. | $143.24 | 2023 | Dexcom G7 Gss (161) |
| Glaxosmithkline, LLC. | $142.21 | 2021 | |
| Novartis Pharmaceuticals Corporation | $105.45 | 2020-2021 | |
| Gilead Sciences, INC. | $64.63 | 2019-2020 | |
| Vifor Pharma, INC. | $42.50 | 2021 | |
| Pfizer INC. | $38.89 | 2019-2021 | |
| Zealand Pharma US, INC. | $36.63 | 2020 | |
| Esperion Therapeutics, INC. | $31.64 | 2020-2021 | |
| Abbvie INC. | $23.31 | 2025 | |
| Merck Sharp & Dohme LLC | $22.16 | 2025 | Gardasil 9, Capvaxive |
| Abbott Laboratories | $21.79 | 2022 | |
| Exact Sciences Corporation | $19.73 | 2025 | The Cologuard Plus Collection Kit |
| Global Blood Therapeutics, INC. | $18.54 | 2020 | |
| Redhill Biopharma INC. | $18.14 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14.76 | 2025 | Breztri |
| Ultragenyx Pharmaceutical INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Mier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.